Cerebrospinal fluids

Central Nervous System
http://zircon.mcli.dist.maricopa.edu

Cerebral Spinal Fluid & The Meninges
http://faculty.sdmiramar.edu

Cerebrospinal Fluid Dennis Stevens
http://chua2.fiu.edu/

Urinalysis and Body Fluids
http://www.austincc.edu/

CSF Physiology and Cerebral Blood Flow
Keith R. Lodhia, MD,MS
https://wiki.umms.med.umich.edu/

Cerebrospinal fluid (CSF)
http://www.uta.edu/

CSF Functions
http://36-454-f11.wiki.uml.edu/

CSF tau
Chris Clark
http://www.alz.washington.edu/

Brain Tidbit I:  Nourishment to the brain
http://larryfrolich.com/anatomyphysiologyone

Body Fluids
http://www9.georgetown.edu

Lumbar Puncture
http://www.meddean.luc.edu

Review CSF analysis in meningitis
http://www.med.unc.edu

Hydrocephalus
By: Abraham, De La Garza and Liana Sencion
http://www.laredo.edu


151 Published articles of CSF

1. [Acid-base balance and partial pressures of blood and cerebrospinal fluids gases in acute cerebrovascular accidents].
2. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
3. [Antizymic properties of cerebrospinal fluids].
4. [Changes in lipid peroxides and superoxide dismutase as incubation of in vitro erythrocytes with cerebrospinal fluids and the action of various scavengers of free radicals].
5. [Comparison of clinical data in cerebrospinal fluids of patients with disseminated sclerosis with normal and increased level of gamma globulins].
6. [Comparison of culture and polymerase chain reaction methods for the detection of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and middle ear effusions].
7. [Composition of the cerebrospinal fluid in the normal newborn infant. Cytology, proteins and bilirubin in 79 samples of cerebrospinal fluids].
8. [Conclusions drawn from the use of the classic reactions for the diagnosis of syphilis in the normal and pathologic blood and cerebrospinal fluids in the native African; the reaction of V.D.R.L. and Suchet's technics].
9. [Content of free and bound acetylcholine in normal and pathological cerebrospinal fluids].
10. [Cytopathic effect of 2 strains of mumps virus isolated from cerebrospinal fluids in cell cultures and localization of the viral antigen by immunofluorescence].
11. [Determination of free amino acids in cerebrospinal fluids and their importance for clinical practice].
12. [Diagnostic significance of lactate and lysozyme concentrations in cerebrospinal fluids inchildren with meningitis (author's transl)].
13. [Distinct dissociation observed during certain evolutive periods of tuberculous meningitis between the glycorrhachia of the lumbar and ventricular cerebrospinal fluids].
14. [Epstein-Barr virus infection and neurological disorders in children-- detection of Epstein-Barr virus genomes in cerebrospinal fluids by polymerase chain reaction technique].
15. [In vitro studies on the determination of the coagulating activity of normal, inflammatory and bloody cerebrospinal fluids].
16. [Intracranial pressure in severe brain injuries. 1st Part: X-ray computed tomography of cerebrospinal fluids and manometry].
17. [Lysozyme and beta2-microglobulin in cerebrospinal fluids from healthy children and in children with diseases of the central nervous system (author's transl)].
18. [Mastix and agargel-electrophoresis. A summary of the findings in 106 cerebrospinal fluids].
19. [Neurochemical investigation on spinocerebellar degeneration--metabolites of biogenic amines in the cerebrospinal fluids].
20. [Nitric oxide, TNF-alpha and IL-8 in cerebrospinal fluids of tuberculous and cryptococcic meningitis].
21. [Opioid peptides in cerebrospinal fluids of epileptic patients].
22. [Rapid diagnosis and therapeutic evaluation of herpes simplex encephalitis using polymerase chain reaction from cerebrospinal fluids].
23. [Rapid enterovirus genotyping in cerebrospinal fluids: a two-year prospective study in a virology laboratory setting].
24. [THE IMMUNO-FLUORESCENCE TEST APPLIED TO THE DIAGNOSIS OF SYPHILIS. COMPARISON WITH THE NELSON TEST AND CLASSICAL SEROLOGY. II. STUDY OF 411 CEREBROSPINAL FLUIDS].
25. [The latex agglutination test for the diagnosis of meningococcal A and C, pneumococcal and H. influenzae b meningitis. A study of 920 purulent cerebrospinal fluids (author's transl)].
26. [Thromboelastographic and immunologic fibrinolysis determinations in inflammatory-changed and artificial blood stained cerebrospinal fluids using fibrinogen substrate].
27. 5-Hydroxyindoles in human cerebrospinal fluids.
28. A bacteriological study of cerebrospinal fluids for pyogenic meningitis in Kenyatta National Hospital, Nairobi.
29. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.
30. Acetylcholine and neuronal activity; acetylcholine and cholines terase activity in the cerebrospinal fluids of patients with epilepsy.
31. Acetylcholine and neuronal activity; cholinesterase patterns and acetylcholine in the cerebrospinal fluids of patients with craniocerebral trauma.
32. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients.
33. Antibody responses to Toxoplasma gondii antigens in aqueous and cerebrospinal fluids of cats infected with T. gondii and FIV.
34. Anti-galactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA).
35. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.
36. Apo A-I and apo E concentrations in cerebrospinal fluids of patients with acute meningitis.
37. Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases.
38. Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis.
39. Autolysis in normal and pathological cerebrospinal fluids.
40. Automated fluorescent treponemal antibody (AFTA) test for cerebrospinal fluids in the diagnosis of neurosyphilis.
41. Biochemical evidence for viral-like characteristics in cerebrospinal fluids of brain tumor patients.
42. Biochemical studies on sera and cerebrospinal fluids of neurologically normal persons and patients with multiple sclerosis. II. Effect of normal blood sera of various age-groups on purified and crude phosphomoesterases.
43. Biochemical studies on sera or cerebrospinal fluids of neurologically normal persons and patients with multiple sclerosis. III. Phosphomonoesterases, their inhibitors or activators in sera and CSF's of MS cases.
44. Biochemical studies on sera or cerebrospinal fluids of neurologically normal persons and patients with multiple sclerosis. IV. Search for lecithin splitting enzymes and their "natural" inhibitors or activators in the same specimens.
45. Biochemical studies on sera or cerebrospinal fluids of neurologically normal persons and patients with multiple sclerosis. I. Phosphomonoesterases in serumpools of normal persons and the effect of some physiological and pathological factors.
46. BK polyomavirus with archetypal and rearranged non-coding control regions is present in cerebrospinal fluids from patients with neurological complications.
47. Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis.
48. Cerebrospinal fluids containing anti-HSP70 autoantibodies from multiple sclerosis patients augment HSP70-induced proinflammatory cytokine production in monocytic cells.
49. Changes of acetylcholine and choline concentrations in cerebrospinal fluids of normal subjects and patients with dementia of Alzheimer-type.
50. Characterization of classes of intrathecally synthesized antibodies by imprint immunofixation of electrophoretically separated sera and cerebrospinal fluids.
51. Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.
52. Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases.
53. Combining lipidomics and proteomics of human cerebrospinal fluids.
54. Comparison of the fluorescent treponemal antibody test with other tests for syphilis on cerebrospinal fluids.
55. Correlation between culture of Mycobacterium tuberculosis and antimycobacterial antibody in lumbar, ventricular and cisternal cerebrospinal fluids of patients with tuberculous meningitis.
56. Correlation between the isolation of Mycobacterium tuberculosis and estimation of mycobacterial antigen in cisternal, ventricular and lumbar cerebrospinal fluids of patients with tuberculous meningitis.
57. Cytotoxic activity of cerebrospinal fluids (CSF's) against lymphocytes and phagocytes: comparison of normal and systemic lupus erythematosus CSF's.
58. Detection and sequencing of rotavirus VP7 gene from human materials (stools, sera, cerebrospinal fluids, and throat swabs) by reverse transcription and PCR.
59. Detection of antibodies to defined M. tuberculosis antigen (38 kDa) in cerebrospinal fluids of patients with tuberculous meningitis.
60. Detection of enteroviruses in cerebrospinal fluids: enzymatic amplification and hybridization with a biotinylated riboprobe.
61. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.
62. Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification.
63. Detection of HIV RNA levels in intraocular and cerebrospinal fluids in patients with AIDS-related cryptococcosis.
64. Detection of tubercule antigen in cerebrospinal fluids by ELISA for diagnosis of tuberculous meningitis.
65. Determination of copper concentration in blood plasma and in ocular and cerebrospinal fluids using graphite furnace atomic absorption spectroscopy.
66. Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis.
67. Distribution of 5,5 dimethyl-2,4-oxazolidinedione (DMO) in intraocular and cerebrospinal fluids of rabbits. 3. Effect of ammonium chloride and probenecid.
68. Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children.
69. Enzymatic action of cerebrospinal fluids following concussion.
70. Evidence for swelling-induced adenosine and adenine nucleotide release in rat cerebral cortex exposed to monocarboxylate-containing or hypotonic artificial cerebrospinal fluids.
71. Excitatory and inhibitory amino acid levels in the cerebrospinal fluids of children with neurological disorders.
72. Extracellular and cerebrospinal fluids.
73. Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis.
74. False positive reactions in total IgE analysis of amniotic and cerebrospinal fluids.
75. Findings in cerebrospinal fluids of horses infected with West Nile virus: 30 cases (2001).
76. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
77. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury.
78. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
79. Glutamine, glutamic acid, and gamma-aminobutyric acid in cerebrospinal fluids.
80. Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.
81. Herpes simplex virus type 2 and acute aseptic meningitis. Clinical features of cases with isolation of herpes simplex virus from cerebrospinal fluids.
82. Human brain lectin immunoreactive material in cerebrospinal fluids determined by enzyme immunoassay (EIA).
83. Idiotype anti-idiotype complexes in cerebrospinal fluids of multiple sclerosis patients.
84. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides.
85. IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children.
86. Immunoelectrophoretic investigations of normal and pathologic cerebrospinal fluids. Their correlation with findings in human serum.
87. Immunoperoxidase staining for carcinoembryonic antigen in cerebrospinal fluids.
88. Immunoprecipitation of herpes simplex virus type 1 antigens with different antisera and human cerebrospinal fluids.
89. In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis.
90. Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy.
91. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.
92. Intercellular contacts in primate cerebral arteries: acute effects of subarachnoid injection of artificial cerebrospinal fluids, serotonin, and blood.
93. Interpretation of findings in the cerebrospinal fluid; the technique and systematic interpretation of the albumin-globulin ratio in cerebrospinal fluids.
94. Isolation of ECHO virus type 9 from cerebrospinal fluids.
95. Lecithinases in normal and in pathological cerebrospinal fluids (CSF) I.
96. Lipid compounds in cerebrospinal fluids of patients suffering from chronic schizophrenia, epilepsy and oligophrenia.
97. Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis.
98. Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis.
99. Melanotropic-lipolytic peptides in various regions of bovine, simian and human brains and in simian and human cerebrospinal fluids.
100. Melatonin concentrations in human serum, ventricular and lumbar cerebrospinal fluids as an index of the secretory pathway of the pineal gland.
101. Neutralizing antibody and interferon-alpha in cerebrospinal fluids and sera of acute aseptic meningitis.
102. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
103. Oligoclonal bands in cerebrospinal fluids: significance of corresponding bands in serum for diagnosis of multiple sclerosis.
104. Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis.
105. Partial amplification of the measles virus nucleocapsid gene from stored sera and cerebrospinal fluids for molecular epidemiological studies.
106. Passage of thiopental and barbital into ocular and cerebrospinal fluids of dog.
107. Passive haemagglutination test for human neurocysticercosis immunodiagnosis. II--Comparison of two standardized procedures for the passive haemagglutination reagent in the detection of anti-Cysticercus cellulosae antibodies in cerebrospinal fluids.
108. Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1.
109. PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids.
110. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids.
111. Phase contrast MRI quantification of pulsatile volumes of brain arteries, veins, and cerebrospinal fluids compartments: repeatability and physiological interactions.
112. Polarographic studies in cerebrospinal fluids.
113. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial.
114. Poor diagnostic value of adenosine deaminase in pleural, peritoneal & cerebrospinal fluids in tuberculosis.
115. Presence of oligoclonal immunoglobulin G bands and lack of matrix protein antibodies in cerebrospinal fluids and sera of ferrets with measles virus encephalitis.
116. Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma.
117. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.
118. Prevalence of autoantibody in cerebrospinal fluids from dogs with various CNS diseases.
119. Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry.
120. QIAamp MinElute virus kit effectively extracts viral nucleic acids from cerebrospinal fluids and nasopharyngeal swabs.
121. Quantitative estimation of serum proteins in the cerebrospinal fluids by means of the quantitative precipitation reaction in free buffer solution.
122. QUANTITATIVE ESTIMATION OF THE GAMMA C-GLOBULIN IN NORMAL AND PATHOLOGICAL CEREBROSPINAL FLUIDS BY AN IMMUNOCHEMICAL METHOD.
123. Radioimmunoassay for detecting Mycobacterium tuberculosis antigen in cerebrospinal fluids of patients with tuberculous meningitis.
124. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
125. Redox-reactive autoantibodies in cerebrospinal fluids.
126. Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.
127. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.
128. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.
129. Sensitivity and specificity of enzyme-linked immunosorbent assay in the detection of antigen in tuberculous meningitis cerebrospinal fluids.
130. Sensitivity of a radioimmunoassay method for detection of certain viral antibodies in sera and cerebrospinal fluids.
131. Sera and cerebrospinal fluids from normal uninfected sheep contain a visna virus inhibiting factor.
132. Serial examinations of anti-GFAP autoantibodies in cerebrospinal fluids in canine necrotizing meningoencephalitis.
133. Spectrophotometrical determinations of nucleic acids and nucleases in cerebrospinal fluids after cerebral concussion.
134. Stacking, derivatization, and separation by capillary electrophoresis of amino acids from cerebrospinal fluids.
135. Strains of Coxsackie virus type A-9 and ECHO virus type 9 recovered from cerebrospinal fluids.
136. Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
137. Studies on 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) levels in human urine, plasma and cerebrospinal fluids, and their significance in studies of depression.
138. Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.
139. The content and characterization of cholinesterases in human cerebrospinal fluids.
140. The differential cytology of cerebrospinal fluids prepared by cytocentrifugation.
141. The distribution of 5,5-dimethyl-2,4-oxazoli-dinedione (DMO) in ocular and cerebrospinal fluids.
142. The electrophoretic pattern of serum bilirubin, ascitic and cerebrospinal fluids: a study of 232 cases of icterus.
143. The functional morphology of the outflow systems of ocular and cerebrospinal fluids.
144. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
145. The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease.
146. Thyrotropin-releasing hormone and cyclo (His-Pro)-like immunoreactivities in the cerebrospinal fluids of 'normal' infants and adults, and patients with various neuropsychiatric and neurologic disorders.
147. Two-centre study comparing DNA preparation and PCR amplification protocols for herpes simplex virus detection in cerebrospinal fluids of patients with suspected herpes simplex encephalitis.
148. Ultraspectrophotometric studies on cerebrospinal fluids.
149. Ultraspectrophotometry of cerebrospinal fluids in tumors of the central nervous system.
150. Ultraviolet light absorption in normal and in pathological cerebrospinal fluids.
151. Utilization of polymerase chain reaction on archival cytologic material: a comparison with fresh material with special emphasis on cerebrospinal fluids.